Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Insight Molecular Diagnostics (IMDX) Return on Invested Capital (2020 - 2024)

Insight Molecular Diagnostics' Return on Invested Capital history spans 3 years, with the latest figure at 0.03% for Q3 2024.

  • On a quarterly basis, Return on Invested Capital changed N/A to 0.03% in Q3 2024 year-over-year; TTM through Sep 2024 was 0.03%, a N/A change, with the full-year FY2022 number at 0.0%, up 1.0% from a year prior.
  • Return on Invested Capital hit 0.03% in Q3 2024 for Insight Molecular Diagnostics, down from 0.02% in the prior quarter.
  • Over the last five years, Return on Invested Capital for IMDX hit a ceiling of 0.0% in Q2 2021 and a floor of 0.03% in Q3 2024.
  • Historically, Return on Invested Capital has averaged 0.01% across 3 years, with a median of 0.01% in 2020.
  • The widest YoY moves for Return on Invested Capital: up 0bps in 2021, down 0bps in 2021.
  • Tracing IMDX's Return on Invested Capital over 3 years: stood at 0.01% in 2020, then rose by 3bps to 0.01% in 2021, then tumbled by -232bps to 0.03% in 2024.
  • Business Quant data shows Return on Invested Capital for IMDX at 0.03% in Q3 2024, 0.02% in Q2 2024, and 0.02% in Q1 2024.